Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LOC359819 (mitochondrial ribosomal protein L39 pseudogene; ENSG00000250669) is a human pseudogene derived from the functional MRPL39 gene, which encodes a component of the mitochondrial large ribosomal subunit associated with protein synthesis in mitochondria[3][9][11][1]. The pseudogene does not encode a functional protein but could, theoretically, play regulatory roles at the RNA level, as seen for other pseudogenes—such as acting as noncoding RNAs or regulatory RNA elements[4][6]. However, no specific function, disease association, or drug interaction has been reported for this locus. As it is not protein-coding, it is not relevant as a therapeutic target, biomarker, or druggable entity[3][9][11]. It is mainly annotated for genome completeness and reference. No actionable or structured therapeutic biology or pharmacology is associated with ENSG00000250669/LOC359819 as of current scientific databases[3][9][11].
None applicable. Drugs do not act on this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mitochondrial ribosomal protein L39 pseudogene (LOC359819).